Answers are grounded in this paper and cite their sources.
Tesamorelin is the only FDA-approved therapy to treat abdominal fat accumulation in people with HIV (PWH). Phase III clinical trials were conducted prior to the introduction of integrase inhibitors (INSTIs), which are now a mainstay of HIV antiretroviral therapy.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: